Elastic-vessel arteritis in interleukin-1 receptor antagonist-deficient mice involves effector th1 cells and requires interleukin-1 receptor

Circulation

Volumn 111, Issue 23, 2005, Pages 3135-3140

  Shepherd, Joanna ^a   Nicklin, Martin J H ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Immunohistochemistry; Immunology; Inflammation; Interleukins; Receptors

Indexed keywords

CD4 ANTIGEN; ELASTIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ARCH SYNDROME; AORTA ROOT; ARTERITIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; FEMALE; GIANT CELL ARTERITIS; IMMUNOHISTOLOGY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TH1 CELL;

AGE OF ONSET; ANIMALS; AORTA; ARTERITIS; CELL MOVEMENT; DISEASE MODELS, ANIMAL; ELASTICITY; ENDOTHELIUM, VASCULAR; FEMALE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; TH1 CELLS;

EID: 20544446178     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.519132     Document Type: Article

References (25)

1. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996; 87:2095-2147.
2. Beasley D, McGuiggin ME, Dinarello CA. Human vascular smooth muscle cells produce an intracellular form of interleukin-1 receptor antagonist. Am J Physiol. 1995;269:C961-C968.
3. Dewberry R, Holden H, Crossman D, Francis S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20:2394-2400.
4. Arend WP, Joslin FG, Thomson RC, Hannum CH. An IL-1 inhibitor from human monocyces: production and characterization of biologic properties. J Immunol. 1989;143:1951-1858.
5. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Anna Rev Immunol. 1998;16:27-55.
6. Nicklin MJH, Hughes DE, Barton JL, Ure JM, Duff. Arterial inflammation in mice lacking the interleukin-1 receptor antagonist gene. J. Exp. Med. 2000;191:303-311.
7. Shepherd J, Little MC, Nicklin MJH. Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J Invest Dermatol. 2004;122:665-669.
8. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med. 2000;191:313-320.
9. Nordborg E, Nordborg C. Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment. Rheumatology. 2003;42: 413-421.
10. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002;55:481-486.
11. Ma-Krupa W, Jeon S, Spoerl S, Tedder TF, Goronzy JJ, Weyand CM. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med. 2003;199:173-183.
12. Dal Canto AJ, Virgin HW IV. Animal models of infection-mediated vasculitis. Curr Opin Rheumatol. 1999;11:17-23.
13. Inder SJ, Bobryshev YV, Cherian SM, Lord RS, Masuda K, Yutani C. Accumulation of lymphocytes, dendritic cells, and granulocytes in the aortic wall affected by Takayasu's disease. Angiology. 2000;51:565-579.
14. Ma-Krupa W, Dewan M, Jeon M-S, Kurtin PJ, Younge BR, Goronzy JJ, Weyand CM. Trapping of misdirected dendritic cells in granulomatous lesions of giant cell arteritis. Am J Pathol. 2002;161:C1815-C1823.
15. Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, Maliszewski C, Livingston DJ, Peschon JJ, Morrissey PJ. Phenotypic and functional characterization of mice that lack the IL-1 receptor. J Immunol. 1997;159:3364-3371.
16. Irikura VM, Lagraoui M, Hirsh D. The epistatic relationships IL-1, IL-1 receptor antagonist, and the type I IL-1 receptor. J Immunol. 2002;169: 393-398.
17. Krettek A, Sukhova GK, Libby P. Elastogenesis in human arterial disease. Arterioscler Thromb Vasc Biol. 2003;23:582-587.
18. Gonzalez-Gay MA. Genetic epidemiology in giant cell arteritis polymyalgia rheumatica. Arthritis Res. 2001;3:154-157.
19. Naito S, Arakawa K, Saito S, Toyoda K, Takeshita A. Takayasu's disease: association with HLA-B5. Tissue Antigens. 1978;12;143-145.
20. Numano F, Isohisa I, Maezawa H, Juji T. HLA antigens in Takayasu's disease. Am Heart J. 1979;98:153-159.
21. Weyand CM, Schönberger J, Oppitz U, Hunder NN, Hicok KC, Goronzy JJ. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med. 1994;179:951-960.
22. Martinez-Tabaoda V, Hunder NN, Hunder GG, Weyand CM, Goronzy JJ. Recognition of a tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis. J Mol Med. 1996;74:695-703.
23. Shimizu K, Shichiri M, Libby P, Lee RT, Mitchell RN. Th2-predominant inflammation and blockade of IFN-α signaling induce aneurysms in allografted aortas. J Clin Invest. 2004;114:300-308.
24. Iwakura Y. Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models. Cytokine Growth Factor Rev. 2002; 13:341-355.
25. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatabilicy complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995; 182:389-400.